Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWOG-9704: ASCT vs CHOP/R in Aggressive NHL
NCT00004031Phase 3Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Jul 1997
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of etoposide, carmustine in diffuse large B-cell lymphoma (DLBCL), sponsored by SWOG Cancer Research Network. Started Jul 1997; status: completed.
02
Drugs
etoposidecarmustine
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00004031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004031.